NeoGenomics Inc (NG9.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
At close: 07:26PM CEST
| Previous Close | 13.00 |
| Open | 13.40 |
| Bid | 13.90 x 150000 |
| Ask | 14.30 x 150000 |
| Day's Range | 13.40 - 14.00 |
| 52 Week Range | 10.80 - 18.30 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Apr 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyNeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
Simply Wall St.NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
- GuruFocus.com
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.
© 2024 Yahoo. All rights reserved.